$93.36
-0.05-0.05%
Last update: Oct 7, 4:20 PM
$93.41
N/A
Inhibrx Biosciences Inc
INBXNASDAQ
Inhibrx Biosciences (INBX) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-2.32 | $-1.43 | $-2.45 | $-2.21 |
| Actual | $-2.34 | $-2.15 | $-2.11 | $-2.28 |
| Surprise | -0.86% | -50.3% | +13.9% | -3.17% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-2.38 | $-2.51 | $-2.22 | $-2.15 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Aug 13, 2026 | $-2.34 | $-2.32 | -0.86 % |
| Q1 | May 14, 2026 | $-2.15 | $-1.43 | -50.3 % |
| Q4 | Mar 19, 2026 | $-2.11 | $-2.45 | 13.9 % |
| Q3 | Nov 14, 2025 | $-2.28 | $-2.21 | -3.17 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | Feb 28, 2024 | $1.63M | $50.00K | 3168.0 % |
| Q1 | May 8, 2023 | $17.00K | $150.00K | -88.7 % |
| Q4 | Mar 6, 2023 | $274.00K | $790.00K | -65.3 % |
| Q3 | Nov 7, 2022 | $278.00K | $630.00K | -55.9 % |
